Literature DB >> 26999711

Lifetime Perspectives on Primary Prevention of Atherosclerotic Cardiovascular Disease.

Maarten J G Leening1, Jarett D Berry2, Norrina B Allen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26999711     DOI： 10.1001/jama.2016.1654

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

Authors:  Gijs F N Berkelmans; Soffia Gudbjörnsdottir; Frank L J Visseren; Sarah H Wild; Stefan Franzen; John Chalmers; Barry R Davis; Neil R Poulter; Annemieke M Spijkerman; Mark Woodward; Sara L Pressel; Ajay K Gupta; Yvonne T van der Schouw; Ann-Marie Svensson; Yolanda van der Graaf; Stephanie H Read; Bjorn Eliasson; Jannick A N Dorresteijn
Journal:  Eur Heart J       Date:  2019-09-07       Impact factor: 29.983

2.  Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.

Authors:  Ramachandran S Vasan; Danielle M Enserro; Vanessa Xanthakis; Alexa S Beiser; Sudha Seshadri
Journal:  Circulation       Date:  2022-04-18       Impact factor: 39.918

Review 3.  Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases.

Authors:  Parth Shah
Journal:  Curr Cardiol Rep       Date:  2018-05-19       Impact factor: 2.931

Review 4.  Looking back and thinking forwards - 15 years of cardiology and cardiovascular research.

Authors:  Jonathan M Kalman; Sergio Lavandero; Felix Mahfoud; Matthias Nahrendorf; Magdi H Yacoub; Dong Zhao
Journal:  Nat Rev Cardiol       Date:  2019-09-30       Impact factor: 32.419

5.  Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.

Authors:  Parth Shah; Charles J Glueck; Vybhav Jetty; Naila Goldenberg; Matan Rothschild; Rashid Riaz; Gregory Duhon; Ping Wang
Journal:  Lipids Health Dis       Date:  2016-08-18       Impact factor: 3.876

Review 6.  Can cardiovascular disease guidelines that advise treatment decisions based on absolute risk be improved?

Authors:  Duncan J Campbell
Journal:  BMC Cardiovasc Disord       Date:  2016-11-15       Impact factor: 2.298

Review 7.  Management of Asymptomatic Patients With Positive Coronary Artery Calcium Scans.

Authors:  Mark R Burge; R Philip Eaton; George Comerci; Brendan Cavanaugh; Barry Ramo; David S Schade
Journal:  J Endocr Soc       Date:  2017-06-01

8.  Cardiovascular risk and aging: the need for a more comprehensive understanding.

Authors:  Ljiljana Trtica Majnarić; Zvonimir Bosnić; Tomislav Kurevija; Thomas Wittlinger
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.189

9.  Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments.

Authors:  Maarten J G Leening; M Arfan Ikram
Journal:  PLoS Med       Date:  2018-03-20       Impact factor: 11.069

10.  Prediction of Cardiovascular Disease by the Framingham-REGICOR Equation in the High-Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata.

Authors:  Antonio J Amor; Mercè Serra-Mir; Miguel A Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Montserrat Fitó; Ramón Estruch; Lluis Serra-Majem; Fernando Arós; Nancy Babio; Emilio Ros; Emilio Ortega
Journal:  J Am Heart Assoc       Date:  2017-03-13       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.